Reference
- Vehlow A, Klapproth E, Jin S, et al. Interaction of discoidin domain receptor 1 with a 14-3-3-Beclin-1-Akt1 complex modulates glioblastoma therapy sensitivity. Cell Rep. 2019 Mar 26;26(13):3672–3683.e7.
Autophagic Punctum
DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy
Anne Vehlowa OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany;b National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany;c German Cancer Consortium (DKTK), Partner Site Dresden, and DKFZ, Heidelberg, Germany
https://orcid.org/0000-0002-5381-0547View further author information
https://orcid.org/0000-0002-5381-0547View further author information & Nils Cordesa OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany;d Helmholtz-Zentrum Dresden, Rossendorf, Institute of Radiooncology, OncoRay, Dresden, Germany;e University Hospital Carl Gustav Carus, Faculty of Medicine, Department of Radiation Oncology, Technische Universität Dresden, Dresden, Germany;c German Cancer Consortium (DKTK), Partner Site Dresden, and DKFZ, Heidelberg, GermanyCorrespondence[email protected]
https://orcid.org/0000-0001-5684-629XView further author information
https://orcid.org/0000-0001-5684-629XView further author information